• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

143.97 +7.35 (+5.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
99 100 Next >
News headline image
Earnings Scheduled For August 1, 2025 ↗
August 01, 2025
 
Via Benzinga
News headline image
Moderna's Earnings: A Preview ↗
July 31, 2025
 
Via Benzinga
News headline image
Moderna Announces 10% Layoffs Ahead Of Q2 Report: Retail Now Eyes ‘Good Enough’ Earnings ↗
July 31, 2025
CEO Stéphane Bancel said in a note to employees on Thursday that the move is part of the company’s commitment to reduce annual operating expenses by about $1.5 billion by 2027. 
Via Stocktwits
Topics Artificial Intelligence Supply Chain Workforce
News headline image
Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles ↗
July 31, 2025
Moderna Inc. (NASDAQ: MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty. 
Via Benzinga
News headline image
Moderna Earnings: What To Look For From MRNA
July 30, 2025
Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence Government World Trade
News headline image
Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
July 30, 2025
Via ACCESS Newswire
News headline image
Oscar Health, Surgery Partners, Moderna, Molina Healthcare, and Fortrea Stocks Trade Down, What You Need To Know
July 29, 2025
A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending... 
Via StockStory
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
July 29, 2025
Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption' ↗
July 28, 2025
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program (VICP), describing the system as fundamentally broken... 
Via Benzinga
News headline image
Moderna Announces Data to be Presented at ESMO Congress 2025
July 28, 2025
Via ACCESS Newswire
News headline image
Down 74% Over the Past Year, Is Moderna Stock a Buy? ↗
July 26, 2025
Via The Motley Fool
News headline image
Biotech Is Booming, and This Undervalued REIT Stands to Gain ↗
July 25, 2025
Via The Motley Fool
News headline image
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1
July 25, 2025
Via ACCESS Newswire
News headline image
What's Going On With Moderna Stock Wednesday? ↗
July 23, 2025
Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political uncertainty. 
Via Benzinga
News headline image
Which S&P500 stocks are moving on Wednesday? ↗
July 23, 2025
Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
July 23, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
News headline image
Wednesday's session: gap up and gap down stock in the S&P500 index ↗
July 23, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know
July 18, 2025
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
News headline image
3 of Wall Street’s Favorite Stocks That Fall Short
July 18, 2025
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)
July 15, 2025
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Moderna (NASDAQ:MRNA) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
July 15, 2025
Curious about the top performers within the S&P500 index one hour before the close of the markets on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
News headline image
GSK Seeks FDA Nod To Broaden RSV Vaccine For Younger At-Risk Adults ↗
July 15, 2025
FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the first half of 2026. 
Via Benzinga
News headline image
Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash ↗
July 14, 2025
Via The Motley Fool
News headline image
Why Moderna (MRNA) Stock Is Falling Today
July 14, 2025
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its list of top short ideas for the second half of 2025. 
Via StockStory
Topics ETFs Stocks World Trade
News headline image
Delta Air, Moderna And Coinbase Are Among Top Large Cap Gainers Last Week (July 7-July 11): Are The Others In Your Portfolio? ↗
July 13, 2025
Top performers last week: Venture Global up 18.96% on LNG deal, SoFi up 14.29% on analyst coverage, Delta up 11.91% on earnings, Unity up 9.17% on price forecast, Moderna up 10.66% on FDA approval, PTC... 
Via Benzinga
News headline image
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know
July 11, 2025
A number of stocks fell in the morning session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
News headline image
What's Driving the Market Sentiment Around Moderna? ↗
July 11, 2025
 
Via Benzinga
News headline image
2 Stocks Under $50 on Our Watchlist and 1 to Ignore
July 11, 2025
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months ↗
July 10, 2025
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 vaccine patent dispute. 
Via Benzinga
Topics Intellectual Property
News headline image
Should Politicians Be Allowed to Trade Stocks? The Big Debate
July 10, 2025
A growing chorus of lawmakers, ethics watchdogs, and concerned citizens are reigniting a high-stakes debate: Should U.S. politicians be allowed to buy and sell stocks while in office? Amidst rising... 
Via MarketMinute
Topics Artificial Intelligence Electric Vehicles
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap